Dolby Laboratories (NYSE: DLB) reported Q1 EPS of $1.14, $0.09 better than the analyst estimate of $1.05. Revenue for the quarter came in at $357 million versus the consensus estimate of $337.94 million.

GUIDANCE:

Dolby Laboratories sees Q2 2025 EPS of $1.19-$1.34, versus the consensus of $1.35. Dolby Laboratories sees Q2 2025 revenue of $355-388 million, versus the consensus of $387.2 million.

Dolby Laboratories sees FY2025 EPS of $3.99-$4.14, versus the consensus of $4.06. Dolby Laboratories sees FY2025 revenue of $1.33-1.39 billion, versus the consensus of $1.355 billion.

For earnings history and earnings-related data on Dolby Laboratories (DLB) click here.